Integration of conventional and immune therapy in the treatment of head and neck squamous carcinomas: a rational approach for the development of new protocols.
D000970:Antineoplastic Agents / Q000008:administration & dosage; D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D005069:Evaluation Studies as Topic; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D010347:Patient Care Planning
D000970:Antineoplastic Agents